PANTHERx Rare Becomes Exclusive Provider of KYGEVVI™ for UCB's Groundbreaking Therapy PANTHERx Rare has been selected by UCB as the exclusive pharmacy for KYGEVVI™, enhancing patient access and personalized care for rare diseases.

PANTHERx Rare Becomes Exclusive Provider of KYGEVVI™ for UCB's Groundbreaking Therapy #USA #Pittsburgh #PANTHERx_Rare #KYGEVVI™ #UCB_Group

PANTHERx® Rare Partners with Otsuka for VOYXACT® Nephropathy Treatment PANTHERx® Rare Pharmacy joins Otsuka as the exclusive pharmacy to dispense VOYXACT®, a new treatment for IgA nephropathy aimed at reducing proteinuria in adults.

PANTHERx® Rare Partners with Otsuka for VOYXACT® Nephropathy Treatment #USA #Pittsburgh #IgA_nephropathy #PANTHERx_Rare #VOYXACT

PANTHERx® Rare Becomes Chiesi's Exclusive Partner for MYCAPSSA® Distribution PANTHERx® Rare has been appointed by Chiesi as the exclusive specialty pharmacy for MYCAPSSA®, enhancing access for acromegaly patients.

PANTHERx® Rare Becomes Chiesi's Exclusive Partner for MYCAPSSA® Distribution #United_States #Pittsburgh #PANTHERx_Rare #Chiesi_Group #MYCAPSSA

PANTHERx® Rare Pharmacy Among 2025's Top Workplaces in Pittsburgh PANTHERx® Rare has been recognized as the top workplace in Pittsburgh for large employers, showcasing its commitment to employee satisfaction and leadership.

PANTHERx® Rare Pharmacy Among 2025's Top Workplaces in Pittsburgh #United_States #Pittsburgh #PANTHERx_Rare #Bansi_Nagji

PANTHERx® Rare Partners with Soleno Therapeutics for VYKAT™ XR Distribution PANTHERx® Rare teams up with Soleno Therapeutics to distribute VYKAT™ XR, the first FDA-approved treatment for hyperphagia in Prader-Willi syndrome, enhancing patient care.

PANTHERx® Rare Partners with Soleno Therapeutics for VYKAT™ XR Distribution #United_States #Pittsburgh #PANTHERx_Rare #VYKAT_XR #Prader-Willi_Syndrome

PANTHERx® Rare Chosen by Upsher-Smith for VIGAFYDE™ Distribution to Support Pediatric Patients PANTHERx® Rare has been designated by Upsher-Smith as the specialty pharmacy for VIGAFYDE™, aiding young patients with infantile spasms in need.

PANTHERx® Rare Chosen by Upsher-Smith for VIGAFYDE™ Distribution to Support Pediatric Patients #United_States #Pittsburgh #Upsher-Smith #PANTHERx_Rare #VIGAFYDE

PANTHERx® Rare Collaborates with Ionis for TRYNGOLZA™ Distribution, a Milestone in Rare Disease Treatment PANTHERx® Rare has partnered with Ionis Pharmaceuticals to distribute TRYNGOLZA™, the first FDA-approved treatment for FCS, enhancing patient access.

PANTHERx® Rare Collaborates with Ionis for TRYNGOLZA™ Distribution, a Milestone in Rare Disease Treatment #United_States #Pittsburgh #Ionis_Pharmaceuticals #Tryngolza #PANTHERx_Rare